625 related articles for article (PubMed ID: 30214200)
1. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
2. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X
Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328
[TBL] [Abstract][Full Text] [Related]
3. iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment.
Li L; Yang M; Li R; Hu J; Yu L; Qian X
Anticancer Agents Med Chem; 2021; 21(7):910-918. PubMed ID: 32698755
[TBL] [Abstract][Full Text] [Related]
4. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
[TBL] [Abstract][Full Text] [Related]
5. Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer.
Zhang D; Chu Y; Qian H; Qian L; Shao J; Xu Q; Yu L; Li R; Zhang Q; Wu F; Liu B; Liu Q
Int J Nanomedicine; 2020; 15():735-747. PubMed ID: 32099362
[TBL] [Abstract][Full Text] [Related]
6. Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein.
Chen H; Sha H; Zhang L; Qian H; Chen F; Ding N; Ji L; Zhu A; Xu Q; Meng F; Yu L; Zhou Y; Liu B
Int J Nanomedicine; 2018; 13():5347-5359. PubMed ID: 30254439
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling.
Chen S; Ren Y; Duan P
Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984
[TBL] [Abstract][Full Text] [Related]
8. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer.
Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J
Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559
[No Abstract] [Full Text] [Related]
9. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
10. Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy.
Wang P; Jiang F; Chen B; Tang H; Zeng X; Cai D; Zhu M; Long R; Yang D; Kankala RK; Wang S; Liu Y
Colloids Surf B Biointerfaces; 2020 May; 189():110842. PubMed ID: 32058253
[TBL] [Abstract][Full Text] [Related]
11. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
12. Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma.
Ma C; Wei T; Hua Y; Wang Z; Zhang L
Int J Nanomedicine; 2021; 16():4495-4513. PubMed ID: 34239301
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
Paul B; Gaonkar RH; Dutta D; Dasi R; Mukherjee B; Ganguly S; Das SK
Biomater Adv; 2022 Mar; 134():112714. PubMed ID: 35581094
[TBL] [Abstract][Full Text] [Related]
15. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
[TBL] [Abstract][Full Text] [Related]
16. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
17. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
18. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y
J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313
[TBL] [Abstract][Full Text] [Related]
20. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
